Reference: Palmer, M., & Bhakdi, S. (2021). Long-term persistence of the SARS-CoV-2 spike protein: Evidence and implications. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi examines a study by Bansal et al. that identified the presence of SARS-CoV-2 spike protein in exosomes for up to four months post-vaccination with the Pfizer mRNA vaccine. This prolonged […]
Reference: Palmer, M., & Bhakdi, S. (2021). Long-term persistence of the SARS-CoV-2 spike protein: Evidence and implications. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi discusses a study by Bansal et al. that reveals the prolonged presence of the SARS-CoV-2 spike protein in individuals vaccinated with the Pfizer mRNA vaccine. It highlights that the spike
Reference: Kampf, G. (2021). The epidemiological relevance of the COVID-19-vaccinated population is increasing. The Lancet Regional Health – Europe, 11, 100272. https://doi.org/10.1016/j.lanepe.2021.100272 Summary: High COVID-19 vaccination rates were anticipated to diminish SARS-CoV-2 transmission; however, recent findings suggest the opposite. In the UK, secondary attack rates among household contacts exposed to fully vaccinated individuals were similar
Reference: Iriarte, I., & Phoenix, S. (2021). Understanding relative risk reduction (RRR) and absolute risk reduction (ARR) in vaccine trials. PANDA. https://www.pandata.org/understanding-relative-risk-reduction-and-absolute-risk-reduction-in-vaccine-trials/ Summary: The article discusses the critical distinctions between Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR) in the context of vaccine trials, particularly those for COVID-19. RRR compares the efficacy of one
Reference: Campra, P. (2021). Detection of graphene in COVID-19 vaccines by micro-Raman spectroscopy. Technical Report. Almeria, Spain: Universidad de Almería. Summary: This technical report by Professor Pablo Campra investigates the presence of graphene in various COVID-19 vaccine samples using a technique called micro-Raman spectroscopy. The study screened seven vials from four different vaccine brands, identifying
Summary The Pfizer COVID 19 inoculations have come under scrutiny for potential harm and failure to adhere to established safety protocols. Concerns have been raised regarding biased reporting by pharmaceutical companies, including Pfizer. The trials conducted by Pfizer have been criticised for their design, with flaws in the comparison groups and endpoints. The immunobridging trials
Reference: Thomas, S. J., Moreira, E. D. Jr., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., … & Jansen, K. U. (2021). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. The New England Journal of Medicine, 385(19), 1761-1773. https://doi.org/10.1056/NEJMoa2110345 Summary: The BNT162b2 mRNA vaccine demonstrates high efficacy and safety against Covid-19,
Reference: Thomas, S. J., Moreira, E. D. Jr., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., … & Jansen, K. U. (2021). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. New England Journal of Medicine, 385(19), 1761-1773. https://doi.org/10.1056/NEJMoa2110345 Summary: The article investigates the safety and efficacy of the BNT162b2 mRNA Covid-19